收藏切换
Establishment and optimization of an enzyme-cell based high-throughput screening platform for IDO1 inhibitors
收藏切换
PDF
Fang-fang LAI, Ni-na XUE, Ming JI, Ting-ting DU, Ling LI, Li SHENG, Xiao-guang CHEN*
Acta Pharmaceutica Sinica | 2019, 54(10) : 1868 - 1874
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(10): 1868-1874
Original Articles
Establishment and optimization of an enzyme-cell based high-throughput screening platform for IDO1 inhibitors
Full
Fang-fang LAI, Ni-na XUE, Ming JI, Ting-ting DU, Ling LI, Li SHENG, Xiao-guang CHEN*
Affiliations
  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines/Beijing Key Laboratory of Non-clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2019-10-12 doi: 10.16438/j.0513-4870.2019-0697
Outline
收藏切换

In this study, we used the tumor immunotherapy protein indoleamine 2, 3-dioxygenase 1 (IDO1) as the target, and proposed an enzyme-cell-based tertiary IDO1 inhibitor high throughput screening platform. Firstly, the recombinant human IDO1 protein was expressed by genetic engineering and efficient IDO enzymatic screening system was established. Secondly, A172 cells stimulated with interferon-γ (IFNγ) or constructed plasmid which could highly express human IDO1 protein in HEK293 cells with transient transfection were used to construct the specific IDO1 cell based screening system. Finally, the effect of the compound on kynurenine and tryptophan in mouse plasma was determined by LC/MS/MS method on C57 mice, which could further verify the inhibitory effect of the selected compounds on IDO1 in vivo. The established and optimized enzyme-cell based screening model in this study can efficiently and effectively obtain IDO1 inhibitors in vitro, which lays a good foundation for the rapid development of clinical drugs. Procedures for animal study were performed with approval of the Animal Care and Use Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.

high-throughput  /  tertiary screening platform  /  indoleamine 2, 3-dioxygenase 1  /  inhibitor  /  tumor immunity
Fang-fang LAI, Ni-na XUE, Ming JI, Ting-ting DU, Ling LI, Li SHENG, Xiao-guang CHEN. Establishment and optimization of an enzyme-cell based high-throughput screening platform for IDO1 inhibitors[J]. Acta Pharmaceutica Sinica, 2019 , 54 (10) : 1868 -1874 . DOI: 10.16438/j.0513-4870.2019-0697
Year 2019 volume 54 Issue 10
PDF
140
52
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0697
  • Receive Date:2019-08-29
  • Online Date:2026-01-26
  • Published:2019-10-12
Article Data
Affiliations
History
  • Received:2019-08-29
  • Revised:2019-09-11
Funding
Affiliations
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines/Beijing Key Laboratory of Non-clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0697
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT